权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Fluorescence lifetime method for guided therapy of brain tumors

脑肿瘤引导治疗的荧光寿命法

基本信息

批准号：
7266952
负责人：
Laura Marcu
金额：
$ 10万
依托单位：
MICROSURGEON, INC.
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-08-01 至 2009-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7266952
关键词：
Address Algorithms Arterial Fatty Streak Biological Biomedical Engineering Biopsy Blood Brain Brain Neoplasms Characteristics Classification Clinical Clinical Research Collaborations Complement Computer software Data Analyses Development Devices Diagnosis Diagnostic Diagnostic Imaging Diagnostic Procedure Diagnostic Specificity Discrimination Excision Fiber Optics Fluorescence Fluorescence Spectroscopy Foundations Funding Glioma Histopathology Human Image In Situ Institutes Invasive Knowledge Magnetic Resonance Imaging Measurement Measures Metastatic Meningioma Methodology Methods Microscopic Modality Molecular Movement Nature Neurosurgeon Normal tissue morphology Optics Organ Pathway interactions Patients Phase Recording of previous events Research Risk Small Business Technology Transfer Research Software Design Source Specificity Specimen System Techniques Testing Therapeutic Time Time Study Tissues Ultrasonography Work absorption base brain tissue brain tumor resection improved in vivo knowledge base novel diagnostics prototype research clinical testing time use tumor

项目摘要

DESCRIPTION (provided by applicant): We propose clinical evaluation and optimization studies of time-resolved fluorescence spectroscopy (TR-LIFS) technique for the intraoperative identification of tumor vs. normal brain during neurosurgical resection of brain tumors. A critical need currently for neurosurgeons operating on infiltrative glial neoplasms is the ability to distinguish between normal brain and glial tumor. This project is to demonstrate the feasibility of further development of a fluorescencebased device that will enhance the ability of neurosurgeons to distinguish tumor from normal brain intraoperatively without the need for biopsy. The device will use TR-LIFS technique to identify tumor margins and assess the efficacy of diagnostic procedures. If successful, this work will: (i) enhance the ability of neurosurgeons to distinguish tumor from normal brain tissue intraoperatively, (ii) improved specificity of diagnostic in brain biopsy, and (iii) increase the opportunity of image complete resection of brain tumors and decrease risk of resection of normal brain tissue. By measuring intraoperatively the time-resolved autofluorescence of human brain tumors (glioma, meningioma, metastatic) using an existing TR-LIFS research prototype apparatus and methodology, this STTR Phase I project will address 3 specific aims that combine clinical research and functionality studies over a period of 2 years: (1) To obtain a detailed knowledge of the measurability of time-resolved spectra from human brain tumors and surrounding normal tissue and to evaluate sources of experimental errors and optical loss including brain movements and blood absorption. (2) To identify the optimal TR-LIFS features/parameters which provide the best discrimination between tumor and the normal surrounding tissue by analyzing the characteristics of tissue fluorescence and comparing the spectroscopic findings to the tissue histopathology, immunohistochemical, and conventional pre-and intra-operative diagnostic techniques (MRI, Ultrasound). (3) To develop and test algorithms/software for near real-time TR-LIFS data analysis and brain tissue classification based on a representative subset of spectroscopic features. The result of Phase I will be a basis of knowledge sufficient to permit a TR-LIFS prototype device fabrication, optimized software design, and continued development in Phase II. While this project is initially tailored to brain tumors demarcation, the device could potentially be also applied to diagnosis of other tumor types.

描述（由申请人提供）：我们提出时间分辨荧光光谱（TR-LIFS）技术在脑肿瘤神经外科手术中术中肿瘤与正常脑鉴别的临床评价和优化研究。目前对浸润性神经胶质肿瘤进行手术的神经外科医生的一个关键需求是区分正常脑和神经胶质肿瘤的能力。这个项目是为了证明进一步发展一种基于荧光的设备的可行性，这种设备将提高神经外科医生在手术中区分肿瘤和正常大脑的能力，而不需要活检。该设备将使用TR-LIFS技术来识别肿瘤边缘并评估诊断程序的有效性。如果成功，这项工作将：(i)提高神经外科医生术中区分肿瘤和正常脑组织的能力，（ii）提高脑活检诊断的特异性，（iii）增加图像完全切除脑肿瘤的机会，降低切除正常脑组织的风险。通过使用现有的TR-LIFS研究原型设备和方法测量术中人类脑肿瘤（胶质瘤、脑膜瘤、转移性肿瘤）的时间分辨自身荧光，该STTR I期项目将在2年内解决3个具体目标，结合临床研究和功能研究：(1)获得人类脑肿瘤和周围正常组织的时间分辨光谱可测量性的详细知识，并评估实验误差和光学损失的来源，包括大脑运动和血液吸收。(2)通过分析组织荧光特征，并将光谱结果与组织病理学、免疫组化、常规术前、术中诊断技术（MRI、超声）进行比较，确定最优的TR-LIFS特征/参数，以提供肿瘤与正常周围组织的最佳区分。(3)开发和测试基于代表性光谱特征子集的近实时TR-LIFS数据分析和脑组织分类算法/软件。第一阶段的结果将成为TR-LIFS原型设备制造、优化软件设计和第二阶段继续开发的知识基础。虽然这个项目最初是针对脑肿瘤的划分，但该设备也有可能应用于其他类型肿瘤的诊断。